| A Study on Legal Policies for Introduction of an Advance Environmental Risk Assessment System of Human Pharmaceuticals and Personal Care Products in Korea | |
|---|---|
| 년도 | 2020 |
| 날짜 | 2020 Mar |
| 페이지 / 학회지명 |
20(1), 59-92 / Journal of Law and Politics research |
| 논문저자 | Dong-Young LEE, Kyung-Ho CHOI, Young-Gyoo SHIM |
| Link |
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kc…
277회 연결
|
1 국회입법조사처 환경노동팀 2 서울대학교 보건대학원 3 동아대학교 법학전문대학원 Abstract We use a lot of medicines and personal care products in our daily life. However, these ingredients have been detected in surface water, groundwater, and even drinking water. Also, trace amounts of ingredients have been reported to cause an adverse effect like endocrine disruption, acute or chronic toxicity, mutagenicity to the environment. And except for some countries, environmental impacts are not proactively managed. Therefore, it is important to pay attention to “advance environmental risk assessment” as a scientific and rational decision-making method that can anticipate and analyze the environmental impact based on the precautionary principle. Advance environmental risk assessment system needs to be introduced in three aspects. First, as a sustainable principle for solving environmental problems based on the polluter pays principle and the precautionary principle. Second, the implementation of environmental justice. Third, the system is required as a means of obtaining adequate and sufficient information. So, we explored the main components and the way to introduce the advance environmental risk assessment system on human pharmaceuticals and personal care products through analysis of the domestic and international system. As a result of the analysis, we suggest that the basis for implementing the system should be established by law, and the government should establish quantitative priority criteria to conduct an integrated risk assessment for existing products containing priority components. Also, 4 stages of the phase-tiered approach and supports for long term effects and combined toxicity studies by the government are needed. The cost of producing data should be borne by the enterprise, but the co-payment method needs to be considered. It is important to secure the information rather than to regulate it, and to reinforce the recovery of unused drugs or risk mitigation measures such as packaging and labeling. Keywords: advance environmental risk assessment, human pharmaceuticals, integrated risk assessment, personal care products, PPCPs |
|
연구성과